See more : Yakult Honsha Co.,Ltd. (YKLTF) Income Statement Analysis – Financial Results
Complete financial analysis of Medicover AB (publ) (MCVEF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Medicover AB (publ), a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Manila Electric Company (MAEOY) Income Statement Analysis – Financial Results
- Xinyuan Property Management Service (Cayman) Ltd. (1895.HK) Income Statement Analysis – Financial Results
- Mufin Green Finance Limited (MUFIN.BO) Income Statement Analysis – Financial Results
- Hormel Foods Corporation (0J5Z.L) Income Statement Analysis – Financial Results
- Public Power Corporation S.A. (PPC.AT) Income Statement Analysis – Financial Results
Medicover AB (publ) (MCVEF)
About Medicover AB (publ)
Medicover AB (publ) provides healthcare and diagnostic services in Germany, Sweden, Poland, Turkey, Belarus, Bulgaria, Georgia, Hungary, Serbia, Moldova, Ukraine, and India. It operates through two segment, Healthcare Services and Diagnostic Services. The company's diagnostic services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology. The company operates 97 clinical laboratories, 733 blood-drawing points, and 26 clinics in 10 countries; and 117 medical clinics, 20 fertility clinics, 52 dental clinics, 25 hospitals, and 25 gyms. It serves corporate and private customers, and patients, as well as public payers. Medicover AB (publ) was founded in 1995 and is headquartered in Stockholm, Sweden.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.75B | 1.51B | 1.38B | 997.80M | 844.40M | 671.60M | 580.20M | 497.30M | 415.60M | 365.30M |
| Cost of Revenue | 1.39B | 1.17B | 982.40M | 734.30M | 637.60M | 510.90M | 438.20M | 377.30M | 314.90M | 277.60M |
| Gross Profit | 359.40M | 335.60M | 395.00M | 263.50M | 206.80M | 160.70M | 142.00M | 120.00M | 100.70M | 87.70M |
| Gross Profit Ratio | 20.58% | 22.22% | 28.68% | 26.41% | 24.49% | 23.93% | 24.47% | 24.13% | 24.23% | 24.01% |
| Research & Development | 0.00 | 4.30M | 2.70M | 2.30M | 1.50M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 219.20M | 40.50M | 34.50M | 24.80M | 25.70M | 24.40M | 25.00M | 20.50M | 15.00M | 13.20M |
| Selling & Marketing | 77.90M | 23.70M | 20.20M | 15.20M | 16.60M | 13.50M | 10.70M | 9.40M | 9.90M | 8.60M |
| SG&A | 297.10M | 64.20M | 54.70M | 40.00M | 42.30M | 37.90M | 35.70M | 29.90M | 24.90M | 21.80M |
| Other Expenses | 900.00K | 0.00 | 300.00K | 200.00K | 9.10M | 1.60M | 2.90M | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 298.00M | 278.60M | 235.60M | 197.70M | 160.00M | 131.30M | 113.20M | 98.90M | 79.20M | 70.90M |
| Cost & Expenses | 1.69B | 1.45B | 1.22B | 932.00M | 797.60M | 642.20M | 551.40M | 476.20M | 394.10M | 348.50M |
| Interest Income | 4.40M | 2.70M | 1.00M | 900.00K | 1.80M | 1.40M | 200.00K | 100.00K | 0.00 | 300.00K |
| Interest Expense | 51.40M | 34.50M | 20.10M | 18.10M | 13.70M | 4.00M | 4.90M | 4.60M | 2.90M | 2.80M |
| Depreciation & Amortization | 182.40M | 161.90M | 111.00M | 96.20M | 74.20M | 30.40M | 26.20M | 23.30M | 18.00M | 18.10M |
| EBITDA | 257.40M | 215.90M | 274.90M | 151.60M | 121.20M | 61.80M | 59.10M | 40.20M | 37.60M | 33.80M |
| EBITDA Ratio | 14.74% | 14.20% | 19.93% | 15.51% | 15.35% | 9.20% | 10.19% | 8.08% | 9.05% | 9.25% |
| Operating Income | 61.40M | 55.50M | 159.40M | 61.30M | 46.50M | 29.40M | 28.80M | 17.60M | 21.50M | 16.80M |
| Operating Income Ratio | 3.52% | 3.68% | 11.57% | 6.14% | 5.51% | 4.38% | 4.96% | 3.54% | 5.17% | 4.60% |
| Total Other Income/Expenses | -37.80M | -35.70M | -15.60M | -24.00M | -13.20M | 700.00K | -800.00K | -5.30M | -4.80M | -3.90M |
| Income Before Tax | 23.60M | 19.80M | 143.80M | 37.30M | 33.30M | 34.40M | 28.00M | 12.30M | 16.70M | 12.90M |
| Income Before Tax Ratio | 1.35% | 1.31% | 10.44% | 3.74% | 3.94% | 5.12% | 4.83% | 2.47% | 4.02% | 3.53% |
| Income Tax Expense | 5.20M | 5.80M | 37.20M | 10.00M | 8.60M | 7.90M | 7.80M | 5.80M | 7.70M | 8.20M |
| Net Income | 17.60M | 11.80M | 101.80M | 25.80M | 22.50M | 24.60M | 18.70M | 4.30M | 7.50M | 4.30M |
| Net Income Ratio | 1.01% | 0.78% | 7.39% | 2.59% | 2.66% | 3.66% | 3.22% | 0.86% | 1.80% | 1.18% |
| EPS | 0.12 | 0.08 | 0.67 | 0.19 | 0.17 | 0.18 | 0.16 | 0.05 | 0.06 | 0.03 |
| EPS Diluted | 0.12 | 0.08 | 0.67 | 0.19 | 0.17 | 0.18 | 0.16 | 0.05 | 0.06 | 0.03 |
| Weighted Avg Shares Out | 149.36M | 148.71M | 148.35M | 141.75M | 133.34M | 133.34M | 119.19M | 95.01M | 133.34M | 133.34M |
| Weighted Avg Shares Out (Dil) | 149.65M | 148.95M | 148.35M | 141.75M | 133.34M | 133.34M | 119.19M | 96.82M | 133.34M | 133.34M |
Source: https://incomestatements.info
Category: Stock Reports